Last reviewed · How we verify

NCT05911594

IDB Injection Combined With PTNS for Managing Children With OAB Not Responding to Monotherapy

Completed NA Last updated 15 August 2023
What this trial tests

NA trial testing Solifenacin group in BOTOX in 128 participants. Completed in 14 February 2023.

Timeline
14 February 2022
Primary endpoint
14 February 2023
14 February 2023

Quick facts

Lead sponsorBenha University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment128
Start date14 February 2022
Primary completion14 February 2023
Estimated completion14 February 2023
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Benha University

Who can join

Adults 7 to 16, any sex, with BOTOX or Percutaneous Tibial Nerve Stimulation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aimed to evaluate the outcome of simultaneous intradetrusor BOTOX (IDB) injection and Percutaneous tibial nerve stimulation (PTNS) for management of children with recurrent wetness since at least 6 months.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for BOTOX

Currently open trials in the same condition.

Other Benha University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05911594.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing